GALAXYSURF Looks good Positionally
Galaxy Surfactants.
Chart Structure:
- Near Darvas Box Breakout.
- QTL b/o
- Stock took an 11.26% breather after a 53.24% up move.
- From March 2020, Stock moves around (avg.) 50% up after taking an avg. 14% breather.
Relative Strength:
- Stock outperforming index in 1w, 1m, 3m, 6m & 1Y.
- Stock became RS+ on 31st March (as per new ARS)
- Spread chart breakout happening today.
Volume Activity:
- Dry Volumes during the breather.
- Accumulative positive volumes seen in small qty.
- 7 Mutual Funds increased their holdings & 6 Mutual funds decreased their holdings in June. Resulting in Net increase of 5.78 lac shares in holdings of MFs.
- In weekly TF, selling looks exhausted, and buying looks initiated.
Financials:
- Compounded sales growth of Co. (3 years) is 5%
- Compounded Profit growth of Co. (3 years) is 24%
- March results showed a sales jump of 16% but the decline of 7% in Net Profit.
- Upcoming results are scheduled for Sept. 1st week.
Good stock to study & keep an eye upon.
Chart Structure:
- Near Darvas Box Breakout.
- QTL b/o
- Stock took an 11.26% breather after a 53.24% up move.
- From March 2020, Stock moves around (avg.) 50% up after taking an avg. 14% breather.
Relative Strength:
- Stock outperforming index in 1w, 1m, 3m, 6m & 1Y.
- Stock became RS+ on 31st March (as per new ARS)
- Spread chart breakout happening today.
Volume Activity:
- Dry Volumes during the breather.
- Accumulative positive volumes seen in small qty.
- 7 Mutual Funds increased their holdings & 6 Mutual funds decreased their holdings in June. Resulting in Net increase of 5.78 lac shares in holdings of MFs.
- In weekly TF, selling looks exhausted, and buying looks initiated.
Financials:
- Compounded sales growth of Co. (3 years) is 5%
- Compounded Profit growth of Co. (3 years) is 24%
- March results showed a sales jump of 16% but the decline of 7% in Net Profit.
- Upcoming results are scheduled for Sept. 1st week.
Good stock to study & keep an eye upon.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.